PACS医疗集团
PACS
46.91
-0.84
-1.76%
PACS医疗集团
US · PACS
#1809 按市值排名
上市于 2024
46.91
-0.84
-1.76%
实时 - 追踪5344个代码 - 心跳于52秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量增加了1家。
- 机构持股总比例下降了0.7个百分点。
机构持股
- 机构持股比例
- 31.25% -0.66pp
- 机构数量
- 287 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Individual/Insider69.15%
Mutual Fund27.24%
Hedge Fund2.03%
Public Company0.93%
Private Company0.70%
Insurance Company0.16%
Government Pension Fund0.13%
主要股东 截至 2026-09-14
Jason Murray
34.20% · 54.15M 股
Mark Hancock
33.65% · 53.28M 股
Cohen & Steers Capital Management, Inc.
4.67% · 7.40M 股
FMR
3.92% · 6.21M 股
BlackRock
2.62% · 4.16M 股
Crewe Advisors LLC
2.09% · 3.31M 股
American Century Investment Management
1.96% · 3.11M 股
Vanguard Capital Management, LLC
1.36% · 2.16M 股
Columbia Management Investment Advisers, LLC
1.26% · 2.00M 股
Vanguard Portfolio Management, LLC
1.25% · 1.98M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 11次买入 · 39次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Jason Murray | Chairperson & CEO | 34.20% |
| Mark Hancock | Co-Founder & Executive Vice Chairman | 33.65% |
| Joshua Jergensen | President | 0.53% |
| Peter Sanford | President of Providence Administrative Consulting Services, Inc. | 0.24% |
| Derick Apt | Chief Financial Officer | 0.23% |
| Joseph Lee | Chief Compliance Officer | 0.12% |
| John Mitchell | Chief Legal Officer | 0.08% |
| Michelle Lewis | Chief Accounting Officer | 0.07% |
| Evelyn Dilsaver | Independent Director | 0.02% |
| Taylor Leavitt | Independent Director | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-04 | Jason Murray | Chairperson & CEO | Automatic Disposition | -83,308 | $41.13–42.66 |
| 2026-09-15 | Joshua Jergensen | President | Automatic Disposition | -40,000 | $43.08–43.62 |
| 2026-09-14 | Mark Hancock | Co-Founder & Executive Vice Chairman | Automatic Disposition | -300,000 | $42.09–44.91 |
| 2026-09-14 | Mark Hancock | Co-Founder & Executive Vice Chairman | Intent to Sell (Form 144) | -155,682 | $42.47 |
| 2026-09-13 | Mark Hancock | Co-Founder & Executive Vice Chairman | Intent to Sell (Form 144) | -144,318 | $44.57 |
| 2026-09-13 | Jason Murray | Chairperson & CEO | Open Market Disposition | -19,617 | $45.03–45.23 |
| 2026-09-09 | Jason Murray | Chairperson & CEO | Intent to Sell (Form 144) | -253,333 | $44.25 |
| 2026-09-08 | Jason Murray | Chairperson & CEO | Automatic Disposition | -51,887 | $42.68–43.59 |
| 2026-09-02 | Jason Murray | Chairperson & CEO | Automatic Disposition | -68,113 | $42.35–43.36 |
| 2026-08-31 | Jason Murray | Chairperson & CEO | Intent to Sell (Form 144) | -120,000 | $42.25 |
| 2026-08-20 | Jason Murray | Chairperson & CEO | Automatic Disposition | -150,550 | $43.61–44.76 |
| 2026-08-18 | Jason Murray | Chairperson & CEO | Automatic Disposition | -236,116 | $43.34–44.85 |
| 2026-08-17 | Mark Hancock | Co-Founder & Executive Vice Chairman | Other Disposition | -88,000 | -- |
| 2026-08-16 | Jason Murray | Chairperson & CEO | Intent to Sell (Form 144) | -386,666 | $43.69 |
| 2026-08-13 | Patrick Conway | Director | Open Market Disposition | -3,497 | $44.41 |
| 2026-08-11 | Joshua Jergensen | President | Automatic Disposition | -40,000 | $44.53–45.70 |
| 2026-07-14 | Mark Hancock | Co-Founder & Executive Vice Chairman | Automatic Disposition | -13,628 | $45.04–45.05 |
| 2026-07-14 | Mark Hancock | Co-Founder & Executive Vice Chairman | Intent to Sell (Form 144) | -3,332 | $45.05 |
| 2026-07-14 | Joshua Jergensen | President | Automatic Disposition | -40,000 | $44.50–45.76 |
| 2026-07-13 | Mark Hancock | Co-Founder & Executive Vice Chairman | Intent to Sell (Form 144) | -10,296 | $45.04 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:15 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
PACS医疗集团 讨论区 0 条评论